FDA approves new treatment for multiple myeloma
On Nov. 30, the U.S. Food and Drug Administration (FDA) approved Empliciti (elotuzumab) in combination with two other therapies to treat people with multiple myeloma who have received…
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.